CHOmpact: A reduced metabolic model of Chinese hamster ovary cells with enhanced interpretability
Biotechnology and Bioengineering · 2023-09 · 120 (9) · 2479-2493
DOI: 10.1002/bit.28459 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2023-06-05. Written by Ioscani Jiménez Del Val and 6 co-authors. Institution: School of Chemical & Bioprocess Engineering, University College Dublin, Dublin, Ireland. Major MEDLINE topics: Metabolic Networks and Pathways, Genome. Cited 27 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: Biotechnology and Biological Sciences Research Council, Science Foundation Ireland, Engineering and Physical Sciences Research Council.
Abstract (original language)
Metabolic modeling has emerged as a key tool for the characterization of biopharmaceutical cell culture processes. Metabolic models have also been instrumental in identifying genetic engineering targets and developing feeding strategies that optimize the growth and productivity of Chinese hamster ovary (CHO) cells. Despite their success, metabolic models of CHO cells still present considerable challenges. Genome‐scale metabolic models (GeMs) of CHO cells are very large (>6000 reactions) and are difficult to constrain to yield physiologically consistent flux distributions. The large scale of GeMs also makes the interpretation of their outputs difficult. To address these challenges, we have developed CHOmpact, a reduced metabolic network that encompasses 101 metabolites linked through 144 reactions. Our compact reaction network allows us to deploy robust, nonlinear optimization and ensure that the computed flux distributions are physiologically consistent. Furthermore, our CHOmpact model delivers enhanced interpretability of simulation results and has allowed us to identify the mechanisms governing shifts in the anaplerotic consumption of asparagine and glutamate as well as an important mechanism of ammonia detoxification within mitochondria. CHOmpact, thus, addresses key challenges of large‐scale metabolic models and will serve as a platform to develop dynamic metabolic models for the control and optimization of biopharmaceutical cell culture processes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Chemical & Bioprocess Engineering, University College Dublin, Dublin, Ireland.
- Manufacturing Science and Technology, BioMarin Pharmaceutical, Cork, Ireland, Ireland.
- GlycoScience Group, National Institute for Bioprocessing Research and Training, Dublin, Ireland.
- Department of Chemical Engineering, Imperial College London, London, UK.
ORCID profiles: Ioscani Jiménez Del Val, Karen M Polizzi
Funding
- Biotechnology and Biological Sciences Research Council
- Science Foundation Ireland
- Engineering and Physical Sciences Research Council
Cite
APA
Jiménez Del Val, I., Kyriakopoulos, S., Albrecht, S., Stockmann, H., Rudd, P. M., Polizzi, K. M., & Kontoravdi, C. (2023). CHOmpact: A reduced metabolic model of Chinese hamster ovary cells with enhanced interpretability. Biotechnology and Bioengineering, 120(9), 2479-2493. https://doi.org/10.1002/bit.28459
Vancouver
Jiménez Del Val I, Kyriakopoulos S, Albrecht S, Stockmann H, Rudd PM, Polizzi KM, et al. CHOmpact: A reduced metabolic model of Chinese hamster ovary cells with enhanced interpretability. Biotechnology and Bioengineering. 2023;120(9):2479-2493. doi:10.1002/bit.28459
BibTeX
@article{JimnezDelVal2023,
author = {Jiménez Del Val, Ioscani and Kyriakopoulos, Sarantos and Albrecht, Simone and Stockmann, Henning and Rudd, Pauline M and Polizzi, Karen M and Kontoravdi, Cleo},
title = {CHOmpact: A reduced metabolic model of Chinese hamster ovary cells with enhanced interpretability},
journal = {Biotechnology and Bioengineering},
year = {2023},
volume = {120},
number = {9},
pages = {2479--2493},
doi = {10.1002/bit.28459}
}
EUVIMED